
DaShenLin
603233.SSDaShenLin Pharmaceutical Group Co., Ltd. Price (603233.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,132,522,507
(0.3152)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
DaShenLin Pharmaceutical Group Co., Ltd.Currency: CNY
YEAR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
3,252,460,226.00
+0% |
3,706,656,074.00
+14% |
4,545,011,007.00
+23% |
5,265,481,859.00
+16% |
6,273,722,022.00
+19% |
7,421,196,903.00
+18% |
8,859,273,708.00
+19% |
11,141,165,082.00
+26% |
14,582,865,282.00
+31% |
16,759,335,264.00
+15% |
21,248,086,692.00
+27% |
24,531,390,152.00
+15% |
|||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 2,063,352,515.00 | 2,264,694,991.00 | 2,714,063,570.00 | 3,105,140,155.00 | 3,750,575,684.00 | 4,433,548,822.00 | 5,169,796,551.00 | 6,742,559,626.00 | 8,973,435,151.00 | 10,365,747,801.00 | 13,216,857,737.00 | 15,724,070,001.00 | |||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
1,189,107,711.00
+0% |
1,441,961,083.00
+21% |
1,830,947,437.00
+27% |
2,160,341,704.00
+18% |
2,523,146,338.00
+17% |
2,987,648,081.00
+18% |
3,689,477,157.00
+23% |
4,398,605,456.00
+19% |
5,609,430,131.00
+28% |
6,393,587,463.00
+14% |
8,031,228,955.00
+26% |
8,807,320,151.00
+10% |
|||||||
Gross Profit Ratio | (0.37%) | (0.39%) | (0.40%) | (0.41%) | (0.40%) | (0.40%) | (0.42%) | (0.39%) | (0.38%) | (0.38%) | (0.38%) | (0.36%) | |||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 495,644.00 | 434,485.00 | 4,700,511.00 | 44,607,460.00 | 74,378,412.00 | 87,598,890.00 | |||||||
General and Administrative | 135,503,535.00 | 166,304,173.00 | 76,506,934.00 | 76,908,634.00 | 98,141,873.00 | 107,442,584.00 | 126,862,326.00 | 141,035,659.00 | 178,840,280.00 | 258,330,600.00 | 282,827,539.00 | 297,128,779.00 | |||||||
Selling, General & Admin... | 898,710,918.00 | 1,070,575,288.00 | 1,199,802,595.00 | 1,378,308,637.00 | 1,673,923,062.00 | 2,040,731,090.00 | 2,622,258,056.00 | 3,061,171,009.00 | 3,677,394,707.00 | 4,550,213,076.00 | 5,468,970,622.00 | 5,950,975,972.00 | |||||||
Selling & Marketing Exp... | 763,207,382.00 | 904,271,115.00 | 1,123,295,661.00 | 1,301,400,003.00 | 1,575,781,188.00 | 1,933,288,506.00 | 2,495,395,730.00 | 2,920,135,350.00 | 3,498,554,427.00 | 4,291,882,476.00 | 5,186,143,083.00 | 5,653,847,193.00 | |||||||
Depreciation and Amortiz... | 25,722,289.00 | 32,418,332.00 | 35,782,663.00 | 42,562,271.00 | 115,759,000.00 | 160,662,202.00 | 237,725,379.00 | 292,445,561.00 | 339,803,877.00 | 1,367,263,550.00 | 1,531,865,959.00 | 1,447,614,309.00 | |||||||
Other Expenses | 3,239,389.00 | 7,261,946.00 | 49,078,070.00 | 7,148,467.00 | 27,594,915.00 | 1,259,787.00 | 1,257,877.00 | 388,349,522.00 | 480,524,488.00 | 603,886,687.00 | 822,991,466.00 | 1,143,572,937.00 | |||||||
Total Operating Expenses | 925,342,508.00 | 1,099,200,370.00 | 1,377,419,018.00 | 1,581,009,160.00 | 1,908,109,394.00 | 2,319,287,184.00 | 2,950,318,934.00 | 3,449,955,018.00 | 4,162,619,707.00 | 5,198,707,223.00 | 6,366,340,502.00 | 7,175,477,079.00 | |||||||
Cost and Exponses | 2,988,695,024.00 | 3,363,895,362.00 | 4,091,482,588.00 | 4,686,149,315.00 | 5,658,685,079.00 | 6,752,836,006.00 | 8,120,115,486.00 | 10,192,514,644.00 | 13,136,054,859.00 | 15,564,455,025.00 | 19,583,198,239.00 | 22,899,547,081.00 | |||||||
Operating Income | |||||||||||||||||||
Operating Income |
241,268,351.00
+0% |
315,614,198.00
+31% |
411,362,628.00
+30% |
547,873,159.00
+33% |
578,552,315.00
+6% |
633,316,134.00
+9% |
718,298,280.00
+13% |
918,256,148.00
+28% |
1,447,962,142.00
+58% |
1,040,533,763.00
-28% |
1,420,794,361.00
+37% |
1,631,843,071.00
+15% |
|||||||
Operating Income Ratio | (0.07%) | (0.09%) | (0.09%) | (0.10%) | (0.09%) | (0.09%) | (0.08%) | (0.08%) | (0.10%) | (0.06%) | (0.07%) | (0.07%) | |||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 7,252,233.00 | 0.00 | 4,876,177.00 | 6,926,838.00 | 5,134,650.00 | 8,089,732.00 | 15,566,675.00 | 24,858,393.00 | 49,531,015.00 | 68,270,444.00 | 63,077,078.00 | 85,192,188.00 | |||||||
Interest Expenses | 0.00 | 10,041,695.00 | 25,206,955.00 | 16,431,523.00 | 13,123,672.00 | 18,349,648.00 | 23,974,568.00 | 32,050,810.00 | 11,497,394.00 | 212,043,058.00 | 48,234,855.00 | 275,338,198.00 | |||||||
Total Other Income/Exp... | -20,243,149.00 | 6,020,382.00 | 12,318,989.00 | 6,334,495.00 | -882,502.00 | 1,259,788.00 | 1,257,881.00 | 1,241,409.00 | -1,551,806.00 | 3,378,895.00 | -5,899,748.00 | -4,058,018.00 | |||||||
EBITDA | |||||||||||||||||||
EBITDA | 263,765,202.00 | 342,760,712.00 | 541,704,680.00 | 680,193,724.00 | 655,272,063.00 | 730,738,438.00 | 1,005,307,349.00 | 1,267,365,343.00 | 1,825,384,565.00 | 2,649,788,501.00 | 2,751,246,177.00 | 3,141,618,663.00 | |||||||
EBITDA ratio | (0.08%) | (0.09%) | (0.11%) | (0.12%) | (0.10%) | (0.10%) | (0.10%) | (0.10%) | (0.11%) | (0.14%) | (0.13%) | (0.13%) | |||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 243,522,054.00 | 321,634,580.00 | 423,681,617.00 | 554,207,654.00 | 577,471,469.00 | 634,575,922.00 | 719,556,158.00 | 919,497,557.00 | 1,446,410,329.00 | 1,043,912,657.00 | 1,414,894,611.00 | 1,627,785,053.00 | |||||||
Income Before Tax Ratio | (0.07%) | (0.09%) | (0.09%) | (0.11%) | (0.09%) | (0.09%) | (0.08%) | (0.08%) | (0.10%) | (0.06%) | (0.07%) | (0.07%) | |||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 72,145,387.00 | 96,284,512.00 | 115,350,517.00 | 131,947,602.00 | 148,858,056.00 | 159,965,099.00 | 193,868,223.00 | 222,954,711.00 | 363,390,862.00 | 239,517,973.00 | 335,621,390.00 | 397,123,815.00 | |||||||
Net Income | |||||||||||||||||||
Net Income | 149,183,213.00
+0% |
197,382,181.00
+32% |
265,501,554.00
+35% |
395,434,058.00
+49% |
430,188,669.00
+9% |
474,960,964.00
+10% |
531,633,897.00
+12% |
702,661,961.00
+32% |
1,062,181,101.00
+51% |
791,230,980.00
-26% |
1,035,723,834.00
+31% |
1,166,498,182.00
+13% |
|||||||
Net Income Ratio | (0.05%) | (0.05%) | (0.06%) | (0.08%) | (0.07%) | (0.06%) | (0.06%) | (0.06%) | (0.07%) | (0.05%) | (0.05%) | (0.05%) | |||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.29 | 0.27 | 0.36 | 0.46 | 0.44 | 0.47 | 0.49 | 0.63 | 0.94 | 0.70 | 0.91 | 1.03 | |||||||
Diluted EPS | 0.29 | 0.27 | 0.36 | 0.46 | 0.44 | 0.47 | 0.49 | 0.53 | 0.94 | 0.70 | 0.91 | 1.03 | |||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 506,163,621.00 | 728,875,614.00 | 730,313,500.00 | 866,609,820.00 | 974,496,633.00 | 1,016,145,059.00 | 1,078,298,804.00 | 1,118,793,998.00 | 1,132,993,444.00 | 1,135,531,991.00 | 1,136,103,418.00 | 1,132,522,507.00 | |||||||
Diluted Share Outstanding | 506,163,621.00 | 728,875,614.00 | 730,313,500.00 | 866,637,140.00 | 974,496,633.00 | 1,016,145,059.00 | 1,080,780,442.00 | 1,324,581,887.00 | 1,132,993,444.00 | 1,135,531,991.00 | 1,136,103,418.00 | 1,132,522,507.00 |